Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan J Melenhorst

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cytotherapy|January 17, 2013
When one is better than twoJan J Melenhorst
Current Drug Targets|August 26, 2015
Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for CancerJan J Melenhorst, Simon F Lacey, Felipe Bedoya
Journal of Immunological Methods|February 24, 2007
The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangementsPhillip Scheinberg, Jan J Melenhorst, Brenna J Hill, et al.
Blood|October 28, 2017
Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insightsAmrom E Obstfeld, Noelle V Frey, Keith Mansfield, et al.
Journal of Immunological Methods|April 7, 2016
Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapyFang Chen, David T Teachey, Edward Pequignot, et al.
Scientific Reports|October 31, 2025
NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma modelYee Peng Phoon, Alexandra A Wolfarth, Pauline Funchain, et al.
Scientific Reports|December 18, 2025
Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma modelYee Peng Phoon, Alexandra A Wolfarth, Pauline Funchain, et al.
Blood|December 14, 2011
KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in miceLing Zhao, Jan J Melenhorst, Lemlem Alemu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignanciesMatthias Grube, Katayoun Rezvani, Adrian Wiestner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcomeZachariah A McIver, Jan J Melenhorst, Andrew Grim, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cytotherapy|January 17, 2013
When one is better than twoJan J Melenhorst
Current Drug Targets|August 26, 2015
Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for CancerJan J Melenhorst, Simon F Lacey, Felipe Bedoya
Journal of Immunological Methods|February 24, 2007
The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangementsPhillip Scheinberg, Jan J Melenhorst, Brenna J Hill, et al.
Blood|October 28, 2017
Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insightsAmrom E Obstfeld, Noelle V Frey, Keith Mansfield, et al.
Journal of Immunological Methods|April 7, 2016
Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapyFang Chen, David T Teachey, Edward Pequignot, et al.
Scientific Reports|October 31, 2025
NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma modelYee Peng Phoon, Alexandra A Wolfarth, Pauline Funchain, et al.
Scientific Reports|December 18, 2025
Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma modelYee Peng Phoon, Alexandra A Wolfarth, Pauline Funchain, et al.
Blood|December 14, 2011
KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in miceLing Zhao, Jan J Melenhorst, Lemlem Alemu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignanciesMatthias Grube, Katayoun Rezvani, Adrian Wiestner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcomeZachariah A McIver, Jan J Melenhorst, Andrew Grim, et al.
Pageof 3